January 12, 2015 / 4:18 PM / 3 years ago

BUZZ-Second Sight Medical Products: Retinal device gets Heath Canada approval

1 Min Read

** Medical device maker's shares up 8 pct at $11.74

** Receives Health Canada's approval for retinal implants to treat patients with outer retinal degeneration

** Company's Argus II Retinal Prosthesis is an electronic implant designed to improve vision in those with severe cases of the inherited disease

** Outer retinal degeneration is caused by progressive death of the cells in the region

** Argus II Retinal Prosthesis already approved in U.S.

** Up to Friday's close, stock had risen 20 pct since its debut on Nov. 19

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below